Leadership Overview
Madrigal Pharmaceuticals has 5 executives leading key functions including strategy, human resources, information technology, medical affairs, and legal counsel.
Driven by innovation, Madrigal Pharmaceuticals focuses on developing novel therapeutics for cardiovascular, metabolic, and liver diseases, aiming to significantly improve patient outcomes through targeted scientific advancements.
Driven by innovation, Madrigal Pharmaceuticals focuses on developing novel therapeutics for cardiovascular, metabolic, and liver diseases, aiming to significantly improve patient outcomes through targeted scientific advancements.
Leadership Roles at Madrigal Pharmaceuticals
William Sibold - Chief Executive Officer
William Sibold, the Chief Executive Officer at Madrigal Pharmaceuticals, directs the company's overall strategic vision and operational execution. Sibold guides the development and commercialization of therapeutic candidates targeting cardiovascular, metabolic, and liver diseases. Overseeing all facets of the business, the Chief Executive Officer ensures alignment with the company's mission to advance innovative treatments. This leadership role involves fostering a culture of scientific rigor and driving progress in clinical trials, particularly for the lead candidate MGL-3196. By championing the company's pipeline, William Sibold is pivotal in navigating the complex biopharmaceutical landscape and securing the resources necessary for sustained growth and market impact.
Clint Wallace - Executive Vice President & Chief Human Resources Officer
Clint Wallace, the Executive Vice President & Chief Human Resources Officer at Madrigal Pharmaceuticals, architects the human capital strategy to support the company's growth and innovation objectives. Wallace oversees all aspects of human resources, including talent acquisition, development, compensation, and employee relations, ensuring a robust organizational structure. This executive leadership position is critical for cultivating a high-performing work environment that attracts and retains top scientific and operational talent. By fostering a culture aligned with Madrigal Pharmaceuticals' mission, Clint Wallace ensures that the workforce is equipped to advance therapeutic candidates for cardiovascular, metabolic, and liver diseases. The focus remains on building a cohesive team dedicated to the successful development and commercialization of novel treatments.
Ronald Filippo - Executive Vice President & Chief Information Officer
Ronald Filippo, the Executive Vice President & Chief Information Officer at Madrigal Pharmaceuticals, spearheads the company's technology strategy and digital transformation initiatives. Filippo directs the implementation and management of IT infrastructure, ensuring secure, efficient, and scalable systems that support research, development, and business operations. This critical role involves leveraging technology to enhance data analytics, streamline clinical trial processes, and protect sensitive company information. By optimizing the technological backbone, Ronald Filippo enables Madrigal Pharmaceuticals to accelerate its focus on therapeutic candidates for cardiovascular, metabolic, and liver diseases. The CIO's leadership ensures that information systems are robust and aligned with the company's overarching goals for innovation and market penetration.
David Soergel - Executive Vice President & Chief Medical Officer
David Soergel, the Executive Vice President & Chief Medical Officer at Madrigal Pharmaceuticals, leads the clinical development strategy for the company's pipeline of therapeutic candidates. Soergel oversees the design, execution, and interpretation of clinical trials, particularly for MGL-3196, the lead candidate targeting liver diseases. This executive position is central to advancing treatments for cardiovascular, metabolic, and liver diseases, ensuring scientific integrity and regulatory compliance throughout the development process. By guiding the medical affairs team, David Soergel drives the progression of novel therapies from preclinical research through to regulatory submission. The Chief Medical Officer's expertise is instrumental in translating scientific discoveries into potential life-changing medicines for patients.
Shannon Kelley - Executive Vice President & Chief Legal Officer
Shannon Kelley, the Executive Vice President & Chief Legal Officer at Madrigal Pharmaceuticals, provides comprehensive legal counsel and oversees all legal affairs for the organization. Kelley manages corporate governance, intellectual property, regulatory compliance, and litigation, safeguarding the company's interests. This executive leadership role is essential for navigating the complex legal and regulatory environment inherent in the biopharmaceutical industry. By ensuring adherence to all applicable laws and regulations, Shannon Kelley supports Madrigal Pharmaceuticals' mission to develop and commercialize therapeutic candidates for cardiovascular, metabolic, and liver diseases. The Chief Legal Officer's strategic guidance is critical for mitigating risk and enabling the company's continued innovation and growth.
Explore Leadership Teams in Manufacturing
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership GA
ZP
AH
DL
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.
Company Leadership
WN
VE
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership MM
AA
AG
CL
Founded in 1990, Divi's Laboratories is a pharmaceutical company that specializes in the manufacturing in custom synthesizes generic APIs, intermediates and nutraceutical ingredients. Divi's Laboratories is located in India.
Company Leadership
KL
MJ
Frequently Asked Questions Regarding Madrigal Pharmaceuticals Top Executives and Leadership Team
